Luszczak, Sabina
Simpson, Benjamin S.
Stopka-Farooqui, Urszula
Sathyadevan, Vignesh Krishna
Echeverria, Lina M. Carmona
Kumar, Christopher
Costa, Helena
Haider, Aiman
Freeman, Alex
Jameson, Charles
Ratynska, Marzena
Ben-Salha, Imen
Sridhar, Ashwin
Shaw, Greg
Kelly, John D.
Pye, Hayley
Gately, Kathy A.
Whitaker, Hayley C.
Heavey, Susan
Funding for this research was provided by:
Prostate Cancer UK (TLD-PF16-004)
Movember (TLD-PF16-004)
Article History
Received: 16 April 2020
Accepted: 13 August 2020
First Online: 1 September 2020
Change Date: 11 November 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: Inflection Bioscience provided AUM302 (at the time named IBL-302) free of charge for use in this study, under a material transfer agreement with UCL, and later provided £1000 research funding to cover the purchase of BrdU proliferation assay kits. The authors declare no other conflict or competing interests. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.